Page last updated: 2024-09-03

ra 642 and neotetrazolium

ra 642 has been researched along with neotetrazolium in 1 studies

Compound Research Comparison

Studies (ra 642)	Trials (ra 642)	Recent Studies (post-2010) (ra 642)	Studies (neotetrazolium)	Trials (neotetrazolium)	Recent Studies (post-2010) (neotetrazolium)
20	0	0	51	0	1

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carrasco, T; De La Cruz, JP; Sánchez de la Cuesta, F; Smith-Agreda, JM; Villalobos, MA	1

Other Studies

1 other study(ies) available for ra 642 and neotetrazolium

Article	Year
The pyrimido-pyrimidine derivative RA-642 protects from brain injury in a combined model of permanent focal ischemia and global ischemia reperfusion. Brain research, 1992, Dec-04, Volume: 597, Issue:2 Topics: Animals; Brain; Dipyridamole; Disease Models, Animal; Ischemic Attack, Transient; Lipid Peroxidation; Male; Mitochondria; Mopidamol; Oxidation-Reduction; Pyrimidines; Rats; Rats, Wistar; Reperfusion Injury; Tetrazolium Salts	1992

Article

Year

The pyrimido-pyrimidine derivative RA-642 protects from brain injury in a combined model of permanent focal ischemia and global ischemia reperfusion.

Brain research, 1992, Dec-04, Volume: 597, Issue:2

Topics: Animals; Brain; Dipyridamole; Disease Models, Animal; Ischemic Attack, Transient; Lipid Peroxidation; Male; Mitochondria; Mopidamol; Oxidation-Reduction; Pyrimidines; Rats; Rats, Wistar; Reperfusion Injury; Tetrazolium Salts

1992